Production, characterization, in vitro and ex vivo studies of babchi oil-encapsulated nanostructured solid lipid carriers produced by a hot aqueous titration method

Pharmazie

Volumn 65, Issue 5, 2010, Pages 347-354

  Faiyazuddin, M ^a,b   Akhtar, N ^a   Akhter, J ^b   Suri, S ^a   Shakeel, F ^c   Shafiq, S ^d   Mustafa, Gulam ^a  

^a HAMDARD UNIVERSITY   (India)

^b INTEGRAL UNIVERSITY   (India)

^c AL ARAB MEDICAL UNIVERSITY   (Libyan Arab Jamahiriya)

^d ZYDUS RESEARCH CENTRE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPSORIASIS AGENT; BABCHI OIL; HOT WATER; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG;

ARTICLE; DRUG ANALYSIS; DRUG FORMULATION; DRUG RELEASE; EX VIVO STUDY; IN VITRO STUDY; NANOEMULSION; NANOENCAPSULATION; NONHUMAN; PHYTOTHERAPY; PSORIASIS; STEADY STATE; THERMODYNAMICS; ZETA POTENTIAL;

EID: 77953033301     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2010.9329     Document Type: Article

References (29)

1. Ali J, Akhtar N, Sultana Y, Baboota S, Ahmad S (2008) Thin-layer chromatographic analysis of psoralen in babchi (Psoralea corylifolia) oil. Acta Chromatogr 20: 277-282.
2. Anderson TF, Voorhees JJ (1980) Psoralen photo-chemotherapy of cutaneous disorders. Annual Rev Pharmacol Toxicol 20: 235-257.
3. Asmussen B (1991) Transdermal therapeutic systems: actual state and future developments. Methods Find Exp Clin Pharmacol 13: 343-351.
4. Baboota S, Al-Azaki A, Kohli K, Ali J, Dixit N, Shakeel F (2007) Development and evaluation of a microemulsion formulation for transdermal delivery of terbinafine. PDA J Pharm Sci Technol 61: 276-285. (Pubitemid 47605684)
5. Chang L (2006) Psoriasis Phototherapy: UVA Beats UVB.WebMD Medical News Daniel De Noon, July 18.
6. Craig DQM, Barker SA, Banning D (1995) An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy. Int J Pharm 114: 103-110.
7. Farber EM, Nall ML (1974) The natural history of psoriasis in 5,600 patients. Dermatologica 148: 1-18.
8. Freitas C, Müller RH (1998) Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLNTM) dispersions. Int J Pharm 168: 221-229. (Pubitemid 28349963)
9. Hearst JE (1981) Psoralen photochemistry and nucleic acid structure. J Invest Dermatol 77: 39-44.
10. Hu FQ, Jiang SP, Du YZ, Yuan H (2005) Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Coll Surf B: Biointerface 45: 167-173.
11. Hu FQ, Jiang SP, Du YZ, Yuan H, Ye YQ, Zeng S (2006) Preparation and characteristics of monostearin nanostructured lipid carriers. Int J Pharm 314: 83-89.
12. Jayaraman K, Velayutham A, Vobalaboina R, Venkateswarlu, Rao YM (2009) Lipid nanoparticles for transdermal delivery of flurbiprofen: formulation, in vitro, ex vivo and in vivo studies. Lip Healt Disease 8: 1-15.
13. Jenning V, Thunemann AF, Gohla SH (2000) Characterization of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm 199: 167-177. (Pubitemid 30236188)
14. Lander R, Manger W, Scouloudis M, Ku A, Davis O, Lee A (2000) Gaulin homogenization: A mechanistic study. Biotechnol Prog 16: 80-85.
15. Lawrence MJ, Rees GD (2000) Microemulsion based media as novel drug delivery systems. Adv Drug Deliv Rev 45: 89-121.
16. Leite VC, Santos RF, Chen LC (2004) Psoralen derivatives and longwave ultraviolet irradiation are active in vitro against human melanoma cell line. J Photochem Photobiol B: Biology 76: 49-53.
17. Li P, Ghosh A, Wagner RF, Krill S, Joshi YM, Serajuddin ATM (2005) Effect of combined use of nonionic surfactant on formation of oil-in-water microemulsions. Int J Pharm 288: 27-34. (Pubitemid 39656452)
18. Lippacher A, M̈uller RH, M̈ader K (2002) Semisolid SLN dispersions for topical application: Influence of formulation and production parameters on viscoelastic properties. Eur J Pharm Biopharm 53: 155-160. (Pubitemid 34189788)
19. Lippacher A, M̈uller RH, M̈ader K (2004) Liquid and semisolid SLNTM dispersions for topical application: Rheological characterization. Eur J Pharm Biopharm 58: 561-567. (Pubitemid 39297102)
20. Lowe NJ, Chizhevsky V, Gabriel H (1997) Photo (chemo) therapy: general principles. Clin Dermatol 15: 745-752
21. Mehnert W, M̈ader K (2001) Solid lipid nanoparticles-production, characterization and applications. Adv Drug Deliv Rev 47: 165-196. (Pubitemid 32324113)
22. Miglietta A, Cavalli R, Bocca C, Gabriel L, Gasco MR (2000) Cellular uptake and cytotoxicity of Solid Lipid Nanospheres (SLN) incorporating doxorubicin or paclitaxel. Int J Pharm 210: 61-67. (Pubitemid 32332642)
23. M̈uller RH, Lucks JS (1996) Arzneistofftr̈ager aus festen Lipidteilchen, Feste Lipidnanospharen (SLN). European Patent EP 0605497.
24. Musajo L, Bordin F, Bevilacqua R (1967) Photoreactions at 3655Å linking the 3-4 double bond of furocoumarins with pyrimidine bases. Photochem Photobiol 6: 927-931.
25. Perez C, Castellanos IJ, Costantino HR (2002) Recent trends in stabilizing protein structure upon encapsulation and release from biodegradable polymers. J Pharm Pharmacol 54: 301-313. (Pubitemid 34232331)
26. Shafiq S, Shakeel F, Sushma T, Farhan JA, Khar RK, Ali M (2007a) Design and development of ramipril nanoemulsion formulation: in vitro and in vivo assessment. J Biomed Nanotechnol 3: 28-44.
27. Shafiq S, Shakeel F, Talegaonkar S, Ali J, Baboota S, Ahuja A, Khar RK, Ali M (2007b) Formulation development and optimization using nanoemulsion technique: A technical note. AAPS Pharm Sci Tech 8: E28. (Pubitemid 46620644)
28. Siekmann B, Westesen K (1994) Melt-homogenized solid lipid nanoparticles stabilized by the nontonic surfactant tyloxapol 1. Preparation and particle size determination. Pharm Pharmacol Lett 3: 194-197.
29. Zouboulis CC (2004) Acne and sebaceous gland function. J Clin Dermatol 22: 360-366.